HOTT, STRM, CML, RPC, DDSS, SMSC, PIR, MTCH, CBAI, NWMT

I am presenting a topical review of stocks that were in the news yesterday.  I am wondering if the DDSS news will be enough to move the stock.  I’m not sure why MTCH went down so much despite some great news.

Have a great day in the market!

Jeffrey Dean

Hot Topic Inc. (NASDAQ: HOTT) $7.84 +11.05% Hot Topic March comparable store sales decreased 7.5% (NASDAQ:HOTT), ($HOTT)

Streamline Health Solutions Inc. (NASDAQ: STRM) $2.56 +28.33% Streamline Health Solutions swings to quarterly and full-year profit (NASDAQ:STRM), ($STRM)

Compellent Technologies Inc. (NYSE: CML) $13.38 -23.80% Compellent Technologies cuts Q1 revenue guidance (NYSE:CML), ($CML)

Radient Pharmaceuticals Corp. (AMEX: RPC) $0.72 +89.47% Radient Pharmaceuticals shares rally after company announces its FDA-approved test may change how people screen for early cancer detection (AMEX:RPC), ($RPC)

Labopharm Inc. (NASDAQ: DDSS) $1.47 +2.80% Labopharm subsidiary completes licensing, distribution agreement with Nippon Shinyaku of Japan (NASDAQ:DDSS), ($DDSS)

Standard Microsystems Corp. (NASDAQ: SMSC) $26.12 +8.16% Standard Microsystems shares rise after earnings top estimates (NASDAQ:SMSC), ($SMSC)

Pier 1 Imports Inc. (NYSE: PIR) $8.15 +12.26% Pier 1 Imports shares up on profit report (NYSE:PIR), ($PIR)

Matech Corp. (OTC: MTCH) $0.0055 -20.25% Matech expects to see increased contracts for its revolutionary EFS technology as states pledge significant investments in infrastructure (OTC:MTCH), ($MTCH)

Cord Blood America Inc. (OTC: CBAI) $0.0101 -1.94% Cord Blood America names an advocate for saving cord blood stem cells as official spokesperson (OTC:CBAI), ($CBAI)

NewMarket Technology Inc. (OTC: NWMT) $0.0106 -11.67% New Market Technology expanding operations into Vietnam (OTC:NWMT), ($NWMT)

———————————————————————————————————————————————-

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.